Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jiracek

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
British Journal of Pharmacology|June 1, 1997
Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivationB Vincent, J Jiracek, F Noble, et al.
European Journal of Pharmacology|November 5, 1997
Contribution of endopeptidase 3.4.24.15 to central neurotensin inactivationB Vincent, J Jiracek, F Noble, et al.
British Journal of Pharmacology|June 1, 1997
Examination of the role of endopeptidase 3.4.24.15 in A beta secretion by human transfected cellsN Chevallier, J Jiracek, B Vincent, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 1999
RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sitesV Dive, J Cotton, A Yiotakis, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
British Journal of Pharmacology|June 1, 1997
Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivationB Vincent, J Jiracek, F Noble, et al.
European Journal of Pharmacology|November 5, 1997
Contribution of endopeptidase 3.4.24.15 to central neurotensin inactivationB Vincent, J Jiracek, F Noble, et al.
British Journal of Pharmacology|June 1, 1997
Examination of the role of endopeptidase 3.4.24.15 in A beta secretion by human transfected cellsN Chevallier, J Jiracek, B Vincent, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 1999
RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sitesV Dive, J Cotton, A Yiotakis, et al.
Pageof 1